CoChat
Sign Up
Cited by 207

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

RHOA G17V Induces T Follicular Helper Cell Specification and Promotes Lymphomagenesis

Cortes, Jose R., Ambesi-Impiombato, Alberto, Couronné, Lucile, Quinn, S. Aidan, Kim, Christine S., da Silva Almeida, Ana C., West, Zachary, Belver, Laura, Martin, Marta Sanchez, Scourzic, Laurianne, Bhagat, Govind, Bernard, Olivier A., Ferrando, Adolfo A., Palomero, Teresa·2018·Cancer Cell
DOI 10.1016/j.ccell.2018.01.001PMC PMC5811310
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.ccell.2018.01.001

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 6 references

Research works printed but not linked: 46

  1. Aghajani, 2012, Generation of CD4CreER(T(2)) transgenic mice to study development of peripheral CD4-T cells, Genesis, 50, 908, 10.1002/dvg.22052 · DOI
  2. Aicher, 2000, Characterization of human inducible costimulator ligand expression and function, J. Immunol., 164, 4689, 10.4049/jimmunol.164.9.4689 · DOI
  3. Borroto, 2000, Rho regulates T cell receptor ITAM-induced lymphocyte spreading in an integrin-independent manner, Eur. J. Immunol., 30, 3403, 10.1002/1521-4141(2000012)30:12<3403::AID-IMMU3403>3.0.CO;2-H · DOI
  4. Boulter, 2012, Off the beaten paths: alternative and crosstalk regulation of Rho GTPases, FASEB J., 26, 469, 10.1096/fj.11-192252 · DOI
  5. Burmeister, 2008, ICOS controls the pool size of effector-memory and regulatory T cells, J. Immunol., 180, 774, 10.4049/jimmunol.180.2.774 · DOI
  6. Chang, 1998, The small GTP-binding protein Rho potentiates AP-1 transcription in T cells, Mol. Cell. Biol., 18, 4986, 10.1128/MCB.18.9.4986 · DOI
  7. Choi, 2011, ICOS receptor instructs T follicular helper cell versus effector cell differentiation via induction of the transcriptional repressor BCL6, Immunity, 34, 932, 10.1016/j.immuni.2011.03.023 · DOI
  8. Couronné, 2012, TET2 and DNMT3A mutations in human T cell lymphoma, N. Engl. J. Med., 366, 95, 10.1056/NEJMc1111708 · DOI · Paper page
  9. Crotty, 2014, T follicular helper cell differentiation, function, and roles in disease, Immunity, 41, 529, 10.1016/j.immuni.2014.10.004 · DOI · Paper page
  10. de Leval, 2007, The gene expression profile of nodal peripheral T cell lymphoma demonstrates a molecular link between angioimmunoblastic T cell lymphoma (AITL) and follicular helper T (TFH) cells, Blood, 109, 4952, 10.1182/blood-2006-10-055145 · DOI
  11. del Pozo, 1999, Rho GTPases control migration and polarization of adhesion molecules and cytoskeletal ERM components in T lymphocytes, Eur. J. Immunol., 29, 3609, 10.1002/(SICI)1521-4141(199911)29:11<3609::AID-IMMU3609>3.0.CO;2-S · DOI
  12. Dobin, 2013, STAR: ultrafast universal RNA-seq aligner, Bioinformatics, 29, 15, 10.1093/bioinformatics/bts635 · DOI · Paper page
  13. Dupuis, 2006, Expression of CXCL13 by neoplastic cells in angioimmunoblastic T cell lymphoma (AITL): a new diagnostic marker providing evidence that AITL derives from follicular helper T cells, Am. J. Surg. Pathol., 30, 490, 10.1097/00000478-200604000-00009 · DOI
  14. Federico, 2013, Clinicopathologic characteristics of angioimmunoblastic T cell lymphoma: analysis of the international peripheral T cell lymphoma project, J. Clin. Oncol., 31, 240, 10.1200/JCO.2011.37.3647 · DOI
  15. Finer, 1994, kat: a high-efficiency retroviral transduction system for primary human T lymphocytes, Blood, 83, 43, 10.1182/blood.V83.1.43.43 · DOI
  16. Gigoux, 2009, Inducible costimulator promotes helper T cell differentiation through phosphoinositide 3-kinase, Proc. Natl. Acad. Sci. USA, 106, 20371, 10.1073/pnas.0911573106 · DOI
  17. Goenka, 2011, Cutting edge: dendritic cell-restricted antigen presentation initiates the follicular helper T cell program but cannot complete ultimate effector differentiation, J. Immunol., 187, 1091, 10.4049/jimmunol.1100853 · DOI
  18. Grogg, 2006, Expression of CXCL13, a chemokine highly upregulated in germinal center T-helper cells, distinguishes angioimmunoblastic T cell lymphoma from peripheral T cell lymphoma, unspecified, Mod. Pathol., 19, 1101, 10.1038/modpathol.3800625 · DOI
  19. Heissmeyer, 2013, Molecular control of Tfh-cell differentiation by Roquin family proteins, Immunol. Rev., 253, 273, 10.1111/imr.12056 · DOI
  20. Hsu, 2016, TCR sequencing can identify and track glioma-infiltrating T cells after DC vaccination, Cancer Immunol. Res., 4, 412, 10.1158/2326-6066.CIR-15-0240 · DOI
  21. Iqbal, 2015, Genomic signatures in T cell lymphoma: how can these improve precision in diagnosis and inform prognosis?, Blood Rev., 30, 89, 10.1016/j.blre.2015.08.003 · DOI
  22. Jiang, 2017, CREBBP inactivation promotes the development of HDAC3-dependent lymphomas, Cancer Discov., 7, 38, 10.1158/2159-8290.CD-16-0975 · DOI · Paper page
  23. Johnston, 2009, BCL6 and Blimp-1 are reciprocal and antagonistic regulators of T follicular helper cell differentiation, Science, 325, 1006, 10.1126/science.1175870 · DOI · Paper page
  24. Ko, 2011, Ten-Eleven-Translocation 2 (TET2) negatively regulates homeostasis and differentiation of hematopoietic stem cells in mice, Proc. Natl. Acad. Sci. USA, 108, 14566, 10.1073/pnas.1112317108 · DOI · Paper page
  25. Leconte, 2016, Inducible costimulator (ICOS) potentiates TCR-induced calcium flux by augmenting PLCgamma1 activation and actin remodeling, Mol. Immunol., 79, 38, 10.1016/j.molimm.2016.09.022 · DOI
  26. Li, 2011, Deletion of Tet2 in mice leads to dysregulated hematopoietic stem cells and subsequent development of myeloid malignancies, Blood, 118, 4509, 10.1182/blood-2010-12-325241 · DOI · Paper page
  27. Lu, 2011, Functional and epigenetic studies reveal multistep differentiation and plasticity of in vitro-generated and in vivo-derived follicular T helper cells, Immunity, 35, 622, 10.1016/j.immuni.2011.07.015 · DOI
  28. Mourad, 2008, Clinical, biologic, and pathologic features in 157 patients with angioimmunoblastic T cell lymphoma treated within the Groupe d'Etude des lymphomes de l'adulte (GELA) trials, Blood, 111, 4463, 10.1182/blood-2007-08-105759 · DOI
  29. Muto, 2014, Reduced TET2 function leads to T cell lymphoma with follicular helper T cell-like features in mice, Blood Cancer J., 4, e264, 10.1038/bcj.2014.83 · DOI
  30. Palomero, 2014, Recurrent mutations in epigenetic regulators, RHOA and FYN kinase in peripheral T cell lymphomas, Nat. Genet., 46, 166, 10.1038/ng.2873 · DOI
  31. Piccaluga, 2007, Gene expression analysis of angioimmunoblastic lymphoma indicates derivation from T follicular helper cells and vascular endothelial growth factor deregulation, Cancer Res., 67, 10703, 10.1158/0008-5472.CAN-07-1708 · DOI
  32. Quivoron, 2011, TET2 inactivation results in pleiotropic hematopoietic abnormalities in mouse and is a recurrent event during human lymphomagenesis, Cancer Cell, 20, 25, 10.1016/j.ccr.2011.06.003 · DOI · Paper page
  33. Sakata-Yanagimoto, 2014, Somatic RHOA mutation in angioimmunoblastic T cell lymphoma, Nat. Genet., 46, 171, 10.1038/ng.2872 · DOI
  34. Salameire, 2012, Accurate detection of the tumor clone in peripheral T cell lymphoma biopsies by flow cytometric analysis of TCR-Vbeta repertoire, Mod. Pathol., 25, 1246, 10.1038/modpathol.2012.74 · DOI
  35. Scourzic, 2016, DNMT3A(R882H) mutant and Tet2 inactivation cooperate in the deregulation of DNA methylation control to induce lymphoid malignancies in mice, Leukemia, 30, 1388, 10.1038/leu.2016.29 · DOI
  36. Stone, 2015, ICOS coreceptor signaling inactivates the transcription factor FOXO1 to promote Tfh cell differentiation, Immunity, 42, 239, 10.1016/j.immuni.2015.01.017 · DOI
  37. Subauste, 2000, Rho family proteins modulate rapid apoptosis induced by cytotoxic T lymphocytes and Fas, J. Biol. Chem., 275, 9725, 10.1074/jbc.275.13.9725 · DOI
  38. Wang, 2015, IDH2R172 mutations define a unique subgroup of patients with angioimmunoblastic T cell lymphoma, Blood, 126, 1741, 10.1182/blood-2015-05-644591 · DOI
  39. Warner, 2013, T cell receptor signaling in peripheral T cell lymphoma – a review of patterns of alterations in a central growth regulatory pathway, Curr. Hematol. Malig. Rep., 8, 163, 10.1007/s11899-013-0165-2 · DOI
  40. Weber, 2015, ICOS maintains the T follicular helper cell phenotype by down-regulating Kruppel-like factor 2, J. Exp. Med., 212, 217, 10.1084/jem.20141432 · DOI
  41. Xie, 2014, Age-related mutations associated with clonal hematopoietic expansion and malignancies, Nat. Med., 20, 1472, 10.1038/nm.3733 · DOI · Paper page
  42. Yang, 2016, RhoA orchestrates glycolysis for TH2 cell differentiation and allergic airway inflammation, J. Allergy Clin. Immunol., 137, 231, 10.1016/j.jaci.2015.05.004 · DOI
  43. Yoo, 2014, A recurrent inactivating mutation in RHOA GTPase in angioimmunoblastic T cell lymphoma, Nat. Genet., 46, 371, 10.1038/ng.2916 · DOI
  44. Yu, 2009, Lineage specification and heterogeneity of T follicular helper cells, Curr. Opin. Immunol., 21, 619, 10.1016/j.coi.2009.09.013 · DOI
  45. Yu, 2007, Roquin represses autoimmunity by limiting inducible T cell co-stimulator messenger RNA, Nature, 450, 299, 10.1038/nature06253 · DOI
  46. Zhang, 2014, Gene targeting RhoA reveals its essential role in coordinating mitochondrial function and thymocyte development, J. Immunol., 193, 5973, 10.4049/jimmunol.1400839 · DOI

Cited by

Metadata

Authors
Cortes, J. R., Ambesi-Impiombato, A., Couronné, L., Quinn, S. A., Kim, C. S., da Silva Almeida, A. C., West, Z., Belver, L., Martin, M. S., Scourzic, L., Bhagat, G., Bernard, O. A., Ferrando, A. A., & Palomero, T.
Venue
Cancer Cell
Publisher
Elsevier BV
Published
2018-02
Volume
33
Issue
2
Pages
259-273.e7
ISSN
1535-6108
DOI
10.1016/j.ccell.2018.01.001
PMC
PMC5811310
Cited by
207
References
6
Language
en
Licence
Funders
  • National Cancer Institute (R01 CA197945-01)
  • Leukemia & Lymphoma Society (TRP-6507-17, TRP- 6163-12)
  • Institut National Du Cancer (2013-1-PL BIO-09, INCa-DGOS-INSERM 6043)
  • LNCC
  • ITMO

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review